Gil Blum
Stock Analyst at Needham
(3.01)
# 1,374
Out of 4,944 analysts
408
Total ratings
38.54%
Success rate
0.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTX Nkarta | Reiterates: Buy | $10 | $2.23 | +348.43% | 18 | Aug 13, 2025 | |
| ABSI Absci | Maintains: Buy | $9 → $8 | $3.25 | +146.53% | 5 | Aug 13, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $52.66 | -44.93% | 18 | Jul 28, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.96 | +411.51% | 29 | Jul 21, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $58.31 | +38.92% | 24 | Jul 8, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $2.56 | +603.13% | 6 | May 15, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $72.41 | +45.01% | 23 | Dec 10, 2024 | |
| SRPT Sarepta Therapeutics | Reiterates: Underperform | n/a | $19.77 | - | 38 | Jul 29, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Hold | n/a | $3.05 | - | 22 | Jul 24, 2025 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $7 → $5 | $1.71 | +192.40% | 19 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.24 | +17.92% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $5.63 | +42.10% | 24 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.07 | +161.01% | 29 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.15 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $11.86 | +237.27% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $6.26 | +1,178.98% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $10.85 | +148.85% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $33.25 | +113.53% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.75 | +415.76% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.81 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.41 | +254.61% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.21 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $5.06 | +848.62% | 9 | Aug 2, 2024 |
Nkarta
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.23
Upside: +348.43%
Absci
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.25
Upside: +146.53%
Celcuity
Jul 28, 2025
Reiterates: Buy
Price Target: $29
Current: $52.66
Upside: -44.93%
Autolus Therapeutics
Jul 21, 2025
Reiterates: Buy
Price Target: $10
Current: $1.96
Upside: +411.51%
CRISPR Therapeutics AG
Jul 8, 2025
Reiterates: Buy
Price Target: $81
Current: $58.31
Upside: +38.92%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $2.56
Upside: +603.13%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $72.41
Upside: +45.01%
Sarepta Therapeutics
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $19.77
Upside: -
Rocket Pharmaceuticals
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.05
Upside: -
Mereo BioPharma Group
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $1.71
Upside: +192.40%
Jul 9, 2025
Reiterates: Buy
Price Target: $5
Current: $4.24
Upside: +17.92%
Jul 8, 2025
Reiterates: Buy
Price Target: $8
Current: $5.63
Upside: +42.10%
Jul 1, 2025
Reiterates: Buy
Price Target: $8
Current: $3.07
Upside: +161.01%
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.15
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $11.86
Upside: +237.27%
May 8, 2025
Reiterates: Buy
Price Target: $80
Current: $6.26
Upside: +1,178.98%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $10.85
Upside: +148.85%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $33.25
Upside: +113.53%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.75
Upside: +415.76%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.81
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.41
Upside: +254.61%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.21
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $5.06
Upside: +848.62%